zepbound glp 1 or 2 leads to more weight loss than Wegovy, Eli Lilly says Cigna will stop covering GLP-1

Pain at injection site semaglutide is a recognized local adverse reaction affecting approximately 1.2-1.4% of patients using this GLP-1 receptor agonist for type 2 diabetes or weight management

For those using tirzepatide, understanding the dosing for weight loss in units allows for more granular control

revealed liraglutide improved aerobic glycolysis in astrocyte, and cortices of 5FAD mice (208)

Other side effects include headache, dizziness, increased heart rate, and fatigue

J Pharmacol Exp Ther (2019) 370(2):17281

The condition is often referred to as an eye stroke because it results from impaired circulation within the small blood vessels that supply the optic nerve